![Ken Galbraith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ken Galbraith
Amministratore Delegato presso
ZYMEWORKS INC.
Patrimonio netto: 6 M $ in data 30/06/2026
Profilo
Kenneth Harry Galbraith is currently Chairman & Chief Executive Officer at Zymeworks BC, Inc. since 2022, Chief Executive Officer at Prometic Plasma Resources (USA), Inc., Chairman, President & Chief Executive Officer at Zymeworks, Inc. starting 2026, Director at AudienceView Ticketing Corp., Managing Director at Five Corners Capital, Inc. since 2013, Director at Liminal BioSciences Ltd. since 2016, Director at Kalium Health Ltd. since 2021, Venture Partner at Genesys Capital Partners, Inc., and Executive Partner at Syncona Partners LLP.
Former roles include Chairman & Chief Executive Officer at AnorMED, Inc. in 2006, Chief Executive Officer & Non-Independent Director at Liminal BioSciences, Inc. from 2019 to 2020, Chief Executive Officer at Fairhaven Pharmaceuticals, Inc. from 2017 to 2019, Chairman at Vancouver Aquarium from 2008 to 2010, Independent Director at Arbutus Biopharma Corp.
from 2010 to 2014, Independent Director at MacroGenics, Inc. from 2008 to 2022, Director at Celator Pharmaceuticals Corp.
from 2008 to 2013, Independent Director at Profound Medical Corp.
from 2017 to 2023, Chief Financial Officer & Executive Vice President at QLT, Inc. from 1987 to 2001, Executive-Residence at Syncona Ltd. from 2021 to 2022, and General Partner at Ventures West Management, Inc. from 2007 to 2013.
Education includes an undergraduate degree from the University of British Columbia, conferred in 1985.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ZYMEWORKS INC. 0,31% | 12/01/2026 | 226.842 ( 0,31% ) | 6 M $ | 30/06/2026 |
Posizioni attive di Ken Galbraith
| Società | Posizione | Inizio |
|---|---|---|
| ZYMEWORKS INC. | Amministratore Delegato | 05/01/2022 |
Kalium Health Ltd.
 Kalium Health Ltd. Medical SpecialtiesHealth Technology Develops blood potassium monitoring devices | Direttore/Membro del Consiglio | 01/06/2021 |
Prometic Plasma Resources (USA), Inc.
 Prometic Plasma Resources (USA), Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Amministratore Delegato | - |
Liminal BioSciences Ltd.
 Liminal BioSciences Ltd. BiotechnologyHealth Technology Research and develops molecular drugs | Direttore/Membro del Consiglio | 12/09/2016 |
Genesys Capital Partners, Inc.
 Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital invests in companies located in Canada. The firm focuses on sectors such as biotechnology, pharmaceuticals and medical technology. It participates in early stage capital transactions. | Investitore di Private Equity | - |
Five Corners Capital, Inc.
 Five Corners Capital, Inc. Investment ManagersFinance Five Corners Capital invests in companies located in North America. The firm targets companies in sectors such as biotechnology, communications, energy technology, and information technology. The firm participates in early-stage capital transactions. | Investitore di Private Equity | 01/09/2013 |
AudienceView Ticketing Corp.
 AudienceView Ticketing Corp. Packaged SoftwareTechnology Services Operates as an event commerce platform that connects audiences, operations and engagement across the live event journey | Direttore/Membro del Consiglio | - |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Amministratore Delegato | - |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Investitore di Private Equity | - |
Precedenti posizioni note di Ken Galbraith
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Ken Galbraith
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
87
Relazioni di 1° grado
30
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 30 |
|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Angiotech Pharmaceuticals, Inc.
 Angiotech Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices and pharmaceuticals for oncology, wound closure and ophthalmology | Health Technology |
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for commercializing cardiovascular hospital drugs | Health Technology |
AnorMED, Inc.
 AnorMED, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops metal based therapeutics | Health Technology |
Liminal BioSciences, Inc.
 Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
Novadaq Technologies, Inc.
 Novadaq Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures real-time fluorescence imaging products | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
Syncona Ltd.
 Syncona Ltd. Investment Trusts/Mutual FundsMiscellaneous Acts as Closed-End Investment Fund/Investment Trust | Miscellaneous |
Genesys Capital Partners, Inc.
Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital invests in companies located in Canada. The firm focuses on sectors such as biotechnology, pharmaceuticals and medical technology. It participates in early stage capital transactions. | Finance |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Xenon Pharmaceuticals, Inc.
 Xenon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovering, developing and delivering of therapeutics for neurological & psychiatric disorders | Health Technology |
Ventures West Management, Inc.
 Ventures West Management, Inc. Investment ManagersFinance Ventures West Management invests in early-stage technology companies across Canada. They focus on investments in biotechnology, clean technology and communications. Ventures West Management is an active value-added venture capital partner. The firm contributes resources to ensure that portfolio companies build value. Ventures West often has representation on the board of directors of their portfolio companies. The firm looks for companies with experienced management teams, competitive advantages and attractive markets. They target early-stage companies that are seeking seed or Series A funding. The firm also looks for companies with the potential for a profitable exit within 4 to 6 years | Finance |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celator Pharmaceuticals Corp.
 Celator Pharmaceuticals Corp. BiotechnologyHealth Technology Develops antibody-based therapies to treat cancer | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
NeurAxon, Inc.
 NeurAxon, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers and develops small-molecule antiviral therapeutics | Health Technology |
Vancouver Aquarium
 Vancouver Aquarium Miscellaneous Commercial ServicesCommercial Services Operates aquarium | Commercial Services |
AudienceView Ticketing Corp.
AudienceView Ticketing Corp. Packaged SoftwareTechnology Services Operates as an event commerce platform that connects audiences, operations and engagement across the live event journey | Technology Services |
Augurex Life Sciences Corp.
 Augurex Life Sciences Corp. Medical SpecialtiesHealth Technology Develops biomarkers that transform patient clinical management | Health Technology |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners invests in companies located across the globe. The firm focuses on life science businesses and therapeutic areas.. It participates in early stage capital requirements. | Finance |
Five Corners Capital, Inc.
Five Corners Capital, Inc. Investment ManagersFinance Five Corners Capital invests in companies located in North America. The firm targets companies in sectors such as biotechnology, communications, energy technology, and information technology. The firm participates in early-stage capital transactions. | Finance |
Profound Medical Corp.
 Profound Medical Corp. Medical SpecialtiesHealth Technology Develops and markets medical devices focused on prostate cancer | Health Technology |
Liminal BioSciences Ltd.
Liminal BioSciences Ltd. BiotechnologyHealth Technology Research and develops molecular drugs | Health Technology |
Prometic Plasma Resources (USA), Inc.
Prometic Plasma Resources (USA), Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biopharmaceutical products | Health Technology |
Kalium Health Ltd.
Kalium Health Ltd. Medical SpecialtiesHealth Technology Develops blood potassium monitoring devices | Health Technology |
Fairhaven Pharmaceuticals, Inc.
 Fairhaven Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a biopharmaceutical company that develops novel, small molecule and oral therapeutics for severe inflammatory conditions | Commercial Services |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
